Results 141 to 150 of about 45,940 (218)

Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world (STEER)

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 2403-2415, March 2026.
Abstract Aims To assess the real‐world effectiveness of semaglutide versus tirzepatide in reducing major adverse cardiovascular events (MACE) among patients with overweight/obesity and established atherosclerotic cardiovascular disease (ASCVD) without diabetes in an insured US population.
Lauren Wilson   +6 more
wiley   +1 more source

Hearing Loss in Neuromyelitis Optica Spectrum Disorder: Case Report and Systematic Review. [PDF]

open access: yesJ Clin Med
Kalampokini S   +6 more
europepmc   +1 more source

Unraveling Endocannabinoid Signaling Pathways in Cisplatin‐Induced Ototoxicity

open access: yesThe FASEB Journal, Volume 40, Issue 4, 28 February 2026.
We performed a comprehensive molecular profiling of the endocannabinoid (eCB) system (ECS) in an auditory Hair cell (HC)‐like cell line (1). Afterwards, we developed suitable in vitro and in vivo models of cisplatin‐induced ototoxicity where we identified distinct components of the ECS (CB2R, DAGLβ and ABHD6) as molecular targets of the drug (2 ...
Sakthimala Palaniappan   +12 more
wiley   +1 more source

Sensorineural hearing loss

open access: yes, 2014
Henry Knipe   +2 more
openaire   +2 more sources

Hearing impairment in X-linked hypophosphatemia: a review. [PDF]

open access: yesJBMR Plus
Oh S   +9 more
europepmc   +1 more source

Audiological profile for assessment of sensorineural hearing loss in treatment naïve chronic myeloid leukemia: impact of early TKI treatment on reversibility. [PDF]

open access: yesAnn Hematol
Mamlekar H   +9 more
europepmc   +1 more source

Chudley-McCullough syndrome: A report of a rare syndromic sensorineural hearing loss. [PDF]

open access: yesRadiol Case Rep
Ouqlani C   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy